Influenza virosomes supplemented with GPI-0100 adjuvant: a potent vaccine formulation for antigen dose sparing.
about
Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virusLiposomes as vaccine delivery systems: a review of the recent advances.Vaccination against infectious diseases: what is promising?Is There an Optimal Formulation and Delivery Strategy for Subunit Vaccines?Adjuvantation of Pulmonary-Administered Influenza Vaccine with GPI-0100 Primarily Stimulates Antibody Production and Memory B Cell Proliferation.
P2860
Influenza virosomes supplemented with GPI-0100 adjuvant: a potent vaccine formulation for antigen dose sparing.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Influenza virosomes supplement ...... tion for antigen dose sparing.
@ast
Influenza virosomes supplement ...... tion for antigen dose sparing.
@en
type
label
Influenza virosomes supplement ...... tion for antigen dose sparing.
@ast
Influenza virosomes supplement ...... tion for antigen dose sparing.
@en
prefLabel
Influenza virosomes supplement ...... tion for antigen dose sparing.
@ast
Influenza virosomes supplement ...... tion for antigen dose sparing.
@en
P2860
P50
P1476
Influenza virosomes supplement ...... tion for antigen dose sparing.
@en
P2093
Wouter Ter Veer
P2860
P2888
P356
10.1007/S00430-013-0313-2
P577
2013-09-24T00:00:00Z
P6179
1040390106